Mechanism of TCF21 Downregulation Leading to Immunosuppression of Tumor-Associated Macrophages in Non-Small Cell Lung

Hong Liu1, Run He2, Xuliang Yang3

  • 1Department of Thyroid Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.

Pharmaceutics
|September 28, 2023
PubMed

Insights

Transcription factor 21 (TCF21) is decreased in non-small cell lung cancer (NSCLC). Overexpressing TCF21 promotes anti-tumor immunity by reprogramming tumor-associated macrophages (TAM), offering new therapeutic targets for lung cancer.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality.
  • Identifying novel therapeutic targets for NSCLC is crucial for improving patient outcomes.
  • Tumor-associated macrophages (TAM) play a significant role in the tumor microenvironment and immune suppression.

Purpose of the Study:

  • To investigate the regulatory role of transcription factor 21 (TCF21) in the immunosuppressive function of TAM in NSCLC.
  • To elucidate the mechanism by which TCF21 influences macrophage polarization and T cell activity.
  • To explore the potential of TCF21 as a therapeutic target for NSCLC.

Main Methods:

  • Quantitative analysis of TCF21 expression in lung cancer cells and TAM.
  • Assessment of macrophage polarization (M1/M2) and its impact on T cell viability and anti-tumor activity.
  • Experimental manipulation of TCF21 expression (overexpression) in TAM.
  • Investigation of the relationship between TCF21 and the Notch signaling pathway.

Main Results:

  • TCF21 expression was found to be downregulated in NSCLC cells and TAM.
  • M2-type TAM polarization was associated with reduced CD8+ T cell viability and tumor-killing capacity.
  • Overexpression of TCF21 induced M1 macrophage polarization, enhancing T cell viability.
  • A targeting relationship between TCF21 and the Notch signaling pathway was identified.

Conclusions:

  • TCF21 plays a critical role in regulating TAM polarization and modulating the anti-tumor immune response in NSCLC.
  • TCF21 influences macrophage polarization via the Notch signaling pathway.
  • TCF21 represents a promising novel therapeutic target for enhancing anti-tumor immunity in lung cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K